BACKGROUND/AIMS: Hypercholesterolemia in midlife increases risk for Alzheimer's disease (AD) and contributes to cerebrovascular dysregulation - an early finding in preclinical AD pathology. Statins improve vascular reactivity, but it is unknown if they increase regional cerebral blood flow (CBF) in individuals at risk for AD. METHODS: In a randomized, controlled, double-blind pilot study, 16 asymptomatic middle-aged adults with parental history of AD were randomized to atorvastatin or placebo daily for 4 months. At baseline and month 4, regional CBF was measured using arterial spin-labeling magnetic resonance imaging and endothelial function was measured using brachial artery ultrasound. RESULTS: At baseline, participants with low HDL-cholesterol, higher global vascular risk, and greater endothelial dysfunction had reduced regional CBF in areas of the brain related to memory and learning (all p < 0.03). Using voxel-based analysis, 4 months of atorvastatin increased CBF in bilateral hippocampi, fusiform gyrus, putamen and insular cortices compared to placebo. CONCLUSION: In this pilot study, atorvastatin increased regional CBF in persons at risk for AD. Further research is warranted to confirm whether statins increase CBF in areas of the brain related to memory and learning and whether such perfusion changes are associated with a delay in the onset of AD. CLINICAL TRIAL REGISTRATION: http://clinicaltrials.gov Identifier: NCT00751907.
RCT Entities:
BACKGROUND/AIMS: Hypercholesterolemia in midlife increases risk for Alzheimer's disease (AD) and contributes to cerebrovascular dysregulation - an early finding in preclinical AD pathology. Statins improve vascular reactivity, but it is unknown if they increase regional cerebral blood flow (CBF) in individuals at risk for AD. METHODS: In a randomized, controlled, double-blind pilot study, 16 asymptomatic middle-aged adults with parental history of AD were randomized to atorvastatin or placebo daily for 4 months. At baseline and month 4, regional CBF was measured using arterial spin-labeling magnetic resonance imaging and endothelial function was measured using brachial artery ultrasound. RESULTS: At baseline, participants with low HDL-cholesterol, higher global vascular risk, and greater endothelial dysfunction had reduced regional CBF in areas of the brain related to memory and learning (all p < 0.03). Using voxel-based analysis, 4 months of atorvastatin increased CBF in bilateral hippocampi, fusiform gyrus, putamen and insular cortices compared to placebo. CONCLUSION: In this pilot study, atorvastatin increased regional CBF in persons at risk for AD. Further research is warranted to confirm whether statins increase CBF in areas of the brain related to memory and learning and whether such perfusion changes are associated with a delay in the onset of AD. CLINICAL TRIAL REGISTRATION: http://clinicaltrials.gov Identifier: NCT00751907.
Authors: K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann Journal: Proc Natl Acad Sci U S A Date: 2001-04-10 Impact factor: 11.205
Authors: Mikael Simons; Frank Schwärzler; Dieter Lütjohann; Klaus von Bergmann; Konrad Beyreuther; Johannes Dichgans; Henning Wormstall; Tobias Hartmann; Jörg B Schulz Journal: Ann Neurol Date: 2002-09 Impact factor: 10.422
Authors: M Yamada; Z Huang; T Dalkara; M Endres; U Laufs; C Waeber; P L Huang; J K Liao; M A Moskowitz Journal: J Cereb Blood Flow Metab Date: 2000-04 Impact factor: 6.200
Authors: Miia Kivipelto; Eeva-Liisa Helkala; Mikko P Laakso; Tuomo Hänninen; Merja Hallikainen; Kari Alhainen; Susan Iivonen; Arto Mannermaa; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen Journal: Ann Intern Med Date: 2002-08-06 Impact factor: 25.391
Authors: Kevin S King; Min Sheng; Peiying Liu; Christopher D Maroules; Craig D Rubin; Ron M Peshock; Roderick W McColl; Hanzhang Lu Journal: Neuroradiol J Date: 2018-01-10
Authors: Sara Ponticorvo; Renzo Manara; Josef Pfeuffer; Arianna Cappiello; Sofia Cuoco; Maria Teresa Pellecchia; Renato Saponiero; Donato Troisi; Claudia Cassandro; Marta John; Alfonso Scarpa; Ettore Cassandro; Francesco Di Salle; Fabrizio Esposito Journal: Hum Brain Mapp Date: 2019-02-04 Impact factor: 5.038
Authors: Stacey E Aaron; Tsubasa Tomoto; Rong Zhang; John P Thyfault; Eric D Vidoni; Robert N Montgomery; Jeffrey M Burns; Sandra A Billinger Journal: Eur J Appl Physiol Date: 2022-08-12 Impact factor: 3.346
Authors: Lindsay R Clark; Derek Norton; Sara E Berman; Sterling C Johnson; Barbara B Bendlin; Oliver Wieben; Patrick Turski; Cynthia Carlsson; Sanjay Asthana; Carey E Gleason; Heather M Johnson Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Alex C Birdsill; Cynthia M Carlsson; Auriel A Willette; Ozioma C Okonkwo; Sterling C Johnson; Guofan Xu; Jennifer M Oh; Catherine L Gallagher; Rebecca L Koscik; Erin M Jonaitis; Bruce P Hermann; Asenath LaRue; Howard A Rowley; Sanjay Asthana; Mark A Sager; Barbara B Bendlin Journal: Obesity (Silver Spring) Date: 2013-05-19 Impact factor: 5.002